↓ Skip to main content

Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care

Overview of attention for article published in European Journal of Clinical Pharmacology, May 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs
2 blogs

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
72 Mendeley
Title
Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care
Published in
European Journal of Clinical Pharmacology, May 2013
DOI 10.1007/s00228-013-1520-x
Pubmed ID
Authors

Arjen F. J. Geerts, Willemijn L. Eppenga, Rob Heerdink, Hieronymus J. Derijks, Michel J. P. Wensing, Toine C. G. Egberts, Peter A. G. M. De Smet

Abstract

To determine whether treatment with nitrofurantoin in women with urinary tract infection (UTI) and renal impairment in primary care is associated with a higher risk of ineffectiveness and/or serious adverse events than in women without renal impairment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Unknown 71 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 18%
Researcher 8 11%
Student > Bachelor 8 11%
Other 5 7%
Student > Postgraduate 4 6%
Other 20 28%
Unknown 14 19%
Readers by discipline Count As %
Medicine and Dentistry 25 35%
Pharmacology, Toxicology and Pharmaceutical Science 10 14%
Nursing and Health Professions 7 10%
Agricultural and Biological Sciences 2 3%
Psychology 2 3%
Other 6 8%
Unknown 20 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2014.
All research outputs
#1,927,642
of 23,577,654 outputs
Outputs from European Journal of Clinical Pharmacology
#119
of 2,597 outputs
Outputs of similar age
#16,506
of 195,046 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#3
of 26 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,597 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,046 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.